Have a feature idea you'd love to see implemented?
Let us know!
TOI Oncology Institute Inc
Price (delayed)
$0.328
Market cap
$24.76M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.79
Enterprise value
$109.34M
Highlights
TOI's revenue is up by 23% year-on-year and by 5% since the previous quarter
The quick ratio has grown by 12% YoY and by 5% from the previous quarter
The EPS has contracted by 18% YoY but it has grown by 2.5% from the previous quarter
TOI's equity has dropped by 66% year-on-year and by 29% since the previous quarter
The gross margin has contracted by 23% YoY and by 9% from the previous quarter
Key stats
What are the main financial stats of TOI
Market
Valuations
Earnings
Shares outstanding
75.49M
Market cap
$24.76M
Enterprise value
$109.34M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.84
Price to sales (P/S)
0.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.3
Revenue
$361.07M
EBIT
-$50.97M
EBITDA
-$44.69M
Free cash flow
-$47.97M
Per share
Balance sheet
Liquidity
EPS
-$0.79
Free cash flow per share
-$0.64
Book value per share
$0.39
Revenue per share
$4.83
TBVPS
$2.09
Total assets
$179.6M
Total liabilities
$150.4M
Debt
$121.01M
Equity
$29.21M
Working capital
$81.11M
Debt to equity
4.14
Current ratio
3.31
Quick ratio
2.87
Net debt/EBITDA
-1.89
Margins
Efficiency
Dividend
EBITDA margin
-12.4%
Gross margin
15.3%
Net margin
-15.6%
Operating margin
-17.6%
Return on assets
-27.8%
Return on equity
-113.1%
Return on invested capital
-22.4%
Return on capital employed
-35.3%
Return on sales
-14.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TOI stock price
How has the Oncology Institute stock price performed over time
Intraday
-4.09%
1 week
-3.39%
1 month
12.87%
1 year
-78.97%
YTD
-83.92%
QTD
0.34%
Financial performance
How have Oncology Institute's revenue and profit performed over time
Revenue
$361.07M
Gross profit
$55.35M
Operating income
-$63.55M
Net income
-$56.35M
Gross margin
15.3%
Net margin
-15.6%
Oncology Institute's operating margin has increased by 45% YoY and by 2.8% from the previous quarter
The operating income rose by 32% year-on-year but it has declined by 2.3% since the previous quarter
The company's net margin rose by 25% YoY and by 8% QoQ
The gross margin has contracted by 23% YoY and by 9% from the previous quarter
Growth
What is Oncology Institute's growth rate over time
Valuation
What is Oncology Institute stock price valuation
P/E
N/A
P/B
0.84
P/S
0.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.3
The EPS has contracted by 18% YoY but it has grown by 2.5% from the previous quarter
TOI's equity has dropped by 66% year-on-year and by 29% since the previous quarter
The stock's P/B is 58% less than its last 4 quarters average of 2.0
The P/S is 96% less than the 5-year quarterly average of 1.6 and 77% less than the last 4 quarters average of 0.3
TOI's revenue is up by 23% year-on-year and by 5% since the previous quarter
Efficiency
How efficient is Oncology Institute business performance
The company's return on equity has shrunk by 102% YoY and by 25% QoQ
The ROS has grown by 23% YoY and by 8% from the previous quarter
The ROA is down by 16% year-on-year and by 3.7% since the previous quarter
The company's return on invested capital fell by 11% YoY
Dividends
What is TOI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TOI.
Financial health
How did Oncology Institute financials performed over time
The total assets is 19% more than the total liabilities
The total assets has contracted by 22% YoY and by 12% from the previous quarter
The quick ratio has grown by 12% YoY and by 5% from the previous quarter
TOI's equity has dropped by 66% year-on-year and by 29% since the previous quarter
The debt to equity has grown by 43% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.